Abstract: The present disclosure relates to a sustained-release injection formulation comprising biodegradable polymer microspheres containing deslorelin as an active ingredient, and a preparation method therefor. The sustained-release microsphere injection containing deslorelin, according to the present disclosure, has good administrability and enables, with a single administration, a deslorelin drug to be maintained at an effective concentration for 6 months without rapid temporary release into the blood of an animal.
Type:
Grant
Filed:
December 17, 2019
Date of Patent:
April 15, 2025
Assignee:
G2GBIO, INC.
Inventors:
Heeyong Lee, Eunyoung Seol, Yongha Na, Juhan Lee
Abstract: The present disclosure relates to a polycaprolactone microsphere containing vitamin C, a filler including the same and a preparation method therefor. Provided is a polycaprolactone microsphere filler obtained by encapsulating vitamin C in polycaprolactone microspheres, which, when injected into a living body, exhibits a rapid collagen formation effect as well as a high tissue restoration property and maintains the effects for a long period of time, thereby showing excellent restoration or volume expansion or wrinkle improvement properties of soft tissues such as cheeks, breasts, nose, lips, and buttocks and reducing wrinkles.
Type:
Grant
Filed:
January 10, 2019
Date of Patent:
February 28, 2023
Assignee:
G2GBIO, INC.
Inventors:
Heeyong Lee, Eunyoung Seol, Kwonhyeok Yoon, Yongha Na
Abstract: The present invention relates to a method for producing biodegradable microspheres having improved safety and storage stability, and a method for producing the same. The present invention provides a method for preparing said biodegradable microspheres while minimizing the morphological changes of microspheres and significantly reducing residual solvents.